🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesMy dad had a heart attack and now I am terrified - will GLP-1 help? — looking for input Page 6

My dad had a heart attack and now I am terrified - will GLP-1 help? — looking for input

PharmHunterJen Thu, Jul 3, 2025 at 12:34 AM 37 replies 2,232 viewsPage 6 of 8
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Jul 15, 2025 at 10:26 AM#26
LibrarianMeg said:
NicoleRaleigh said: ...we don't know the long-term effects of cardiovascular risk...

CRP reduction on cardiovascular risk — this is the lab result that excites me most:

Baseline hsCRP: 12.0 mg/L (high cardiovascular risk)
Month 6 hsCRP: 2.5 mg/L (moderate risk)
Month 12 hsCRP: 0.4 mg/L (low risk)

This level of inflammatory marker reduction is comparable to what you'd see with statin therapy. Combined with the weight loss, my 10-year ASCVD risk score dropped from 19% to 5%. My cardiologist is genuinely impressed.

10 10Dr.EM_Chicago, pete_RVA, CarlaRPh_TPA and 7 others
Reply Quote Save Share Report
SteveThurs
Member
523
2,345
Sep 2024
Wisconsin
Online
Jul 16, 2025 at 9:27 PM#27

Following on from LibrarianMeg — and this may be the naive question:

How long did you give it before you decided it was working?

Last edited: Jul 17, 2025 at 1:27 AM
9 9PurityPaulOR, MaxMetOK, MounjBrad and 6 others
Reply Quote Save Share Report
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Jul 18, 2025 at 8:27 AM#28
TrialTracker_MD said:
CRP reduction on cardiovascular risk — this is the lab result that excites me most: Baseline hsCRP: 12.0 mg/L (high cardiovascular risk) Month 6…

Cardiac biomarkers and cardiovascular risk: my cardiologist ordered advanced cardiac labs given my family history. Results were encouraging:

  • NT-proBNP: 54 pg/mL (normal, cardiac function preserved)
  • Lp(a): 34 nmol/L (genetic, unchanged — expected)
  • ApoB: dropped from 149 to 94 mg/dL (excellent response)
  • Coronary calcium score: 0 (unchanged from baseline — reassuring)

The ApoB reduction is particularly meaningful — it's considered the best single predictor of cardiovascular risk. GLP-1 therapy seems to improve this consistently.

8 8lori_vegas, Dr.PulmRoch, maya_sedona and 5 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
CryptoCarl
Member
789
3,456
May 2024
Arizona
Jul 19, 2025 at 7:26 PM#29
TrialTracker_MD said:
CRP reduction on cardiovascular risk — this is the lab result that excites me most: Baseline hsCRP: 12.0 mg/L (high cardiovascular risk) Month 6…

Lp(a) and cardiovascular risk: a nuance that matters. Unlike most lipid markers, Lp(a) is 90%+ genetically determined and doesn't really change with weight loss or GLP-1 therapy.

My Lp(a) has remained at 84 nmol/L across all time points. If yours is elevated (>50 nmol/L), you need additional risk mitigation strategies regardless of your GLP-1 response. Don't assume your medication is covering all cardiovascular risk factors.

7 7BethLabQueen, ChrisMacros, KetoKyle and 4 others
Reply Quote Save Share Report
PharmHunterJen
Member
567
2,345
Jul 2024
Illinois
Jul 21, 2025 at 6:24 AM#30
BethLabQueen said:
Cardiac biomarkers and cardiovascular risk: my cardiologist ordered advanced cardiac labs given my family history.

Senior perspective on cardiovascular risk: I'm 64 years old and started this journey skeptically. My cardiologist recommended it after years of failed interventions.

14 months later: down 42 lbs, more mobile, pain reduced, medications simplified. My quality of life has improved dramatically. I wish this existed 20 years ago.

To other older adults hesitating: the SELECT trial proved benefit in our age group. You deserve to feel good in your body regardless of age.

35 10mike_mealprep, NicoleRaleigh, james_edin and 32 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register